Page 29 - HOH
P. 29

A28     U.S. NEWS
                      Diahuebs 1 aPRiL 2021

                             Pfizer says its COVID-19 vaccine protects younger teens



                                                                                                                                available  for  adults.  That
                                                                                                                                process  included  holding  a
                                                                                                                                public meeting of outside ex-
                                                                                                                                perts  to  review  and  vote  on
                                                                                                                                the safety and effectiveness of
                                                                                                                                each shot.

                                                                                                                                The  process  for  reviewing
                                                                                                                                data  in  children  could  be
                                                                                                                                shorter,  given  FDA’s  famil-
                                                                                                                                iarity  with  each  vaccine.  An
                                                                                                                                agency  spokeswoman  said
                                                                                                                                the  FDA  had  no  informa-
                                                                                                                                tion to share on how the re-
                                                                                                                                view would work, including
                                                                                                                                whether  additional  public
                                                                                                                                meetings would be required.
                                                                                                                                Another question is when the
                                                                                                                                country  would  have  enough
                                                                                                                                supply of shots — and people
                                                                                                                                to get them into adolescents'
                                                                                                                                arms — to let kids start get-
                                                                                                                                ting in line.
                                                                                                                                Supplies  are  set  to  steadily
                                                                                                                                increase over the spring and
                                                                                                                                summer,  at  the  same  time
                                                                                                                                states  are  opening  vaccina-
                                                                                                                                tions  to  younger,  healthier
                                                                                                                                adults who until now haven't
                                                                                                                                had a turn.

                                                                                                                                Children  represent  about
                                                                                                                                13%  of  COVID-19  cases
                                                                                                                                documented in the U.S. And
                                                                                                                                while  children  are  far  less
                                                                                                                                likely  than  adults  to  get  se-
                                                                                                                                riously  ill,  at  least  268  have
                                                                                                                                died from COVID-19 in the
            ( AP ) - Pfizer announced  ing  antibodies,  somewhat  that  “we  can’t  afford  to  let  statement.                U.S.  alone  and  more  than
            Wednesday  that  its  CO-    higher  than  were  seen  in  our guard down.”                                         13,500  have  been  hospital-
            VID-19 vaccine is safe and  studies of young adults.      Pfizer  and  its  German  part-  AstraZeneca  last  month  be-  ized,  according  to  a  tally  by
            strongly protective in kids                               ner BioNTech in the coming  gan  a  study  of  its  vaccine  the  American  Academy  of
            as  young  as  12,  a  step  to-  Kids  had  side  effects  similar  weeks  plan  to  ask  the  U.S.  among 6- to 17-year-olds in  Pediatrics.  That’s  more  than
            ward  possibly  beginning  to young adults, the company  Food  and  Drug  Administra-  Britain.  Johnson  &  Johnson  die  from  the  flu  in  an  aver-
            shots  in  this  age  group  said.  The  main  side  effects  tion and European regulators  is planning its own pediatric  age year. Additionally, a small
            before  they  head  back  to  are pain, fever, chills and fa-  to  allow  emergency  use  of  studies. And in China, Sino-  number  have  developed  a
            school in the fall.          tigue,  particularly  after  the  the shots starting at age 12.  vac recently announced it has  serious  inflammatory  condi-
                                         second dose. The study will  “We share the urgency to ex-  submitted  preliminary  data  tion  linked  to  the  coronavi-
            Most  COVID-19  vaccines  continue to track participants  pand the use of our vaccine,”  to Chinese regulators show-  rus.
            being  rolled  out  worldwide  for two years for more infor-  Pfizer  CEO  Albert  Bourla  ing its vaccine is safe in chil-
            are  for  adults,  who  are  at  mation about long-term pro-  said  in  a  statement.  He  ex-  dren as young as 3.  Caleb Chung, who turns 13
            higher  risk  from  the  coro-  tection and safety.       pressed “the hope of starting                             later this week, agreed to vol-
            navirus.  Pfizer’s  vaccine  is                           to  vaccinate  this  age  group  While most COVID-19 vac-  unteer after his father, a Duke
            authorized  for  ages  16  and  Dr.  Philip  J.  Landrigan  of  before  the  start  of  the  next  cines  being  used  globally  University  pediatrician,  pre-
            older.  But  vaccinating  chil-  Boston  College  said  the  re-  school  year"  in  the  United  were  first  tested  in  tens  of  sented the option. He doesn't
            dren of all ages will be critical  sults are encouraging.  States.                     thousands  of  adults,  pedi-  know if he received the vac-
            to stopping the pandemic —                                                             atric  studies  won’t  need  to  cine or a placebo.
            and  helping  schools,  at  least  “It’s hard to get kids to com-  Pfizer isn’t the only company  be  nearly  as  large.  Scientists
            the upper grades, start to look  ply  with  masking  and  dis-  seeking to lower the age limit  have safety information from  “Usually  I’m  just  at  home
            a  little  more  normal  after  tancing,  so  something  that  for  its  vaccine.  Results  also  those studies and from sub-  doing  online  school  and
            months of disruption.        gives  them  hard  protection  are expected by the middle of  sequent vaccinations  in  mil-  there’s not much I can really
                                         and  takes  them  out  of  the  this year from a U.S. study of  lions more adults.     do  to  fight  back  against  the
            In the vaccine study of 2,260  mix of spreading the virus is  Moderna’s vaccine in 12- to                           virus,” Caleb said in a recent
            U.S.  volunteers  ages  12  to  all for the good,” said Land-  17-year-olds.           One key question is the dos-  interview. The study “was re-
            15, preliminary data showed  rigan, who was not involved                               age:  Pfizer  gave  the  12-and-  ally  somewhere  that  I  could
            there were no cases of COV-  in the study.                But in a sign that the findings  older  participants  the  same  actually help out.”
            ID-19 among fully vaccinat-                               were  promising,  the  FDA  dose  adults  receive,  while
            ed  adolescents  compared  to  It’s another positive develop-  already  allowed  both  com-  testing  different  doses  in  His  father,  Dr.  Richard
            18 among those given dum-    ment in the race against the  panies  to  begin  U.S.  studies  younger children.      Chung, said he’s proud of his
            my shots, Pfizer reported.   virus  even  as  U.S.  cases,  at  in  children  11  and  young-                       son and all the other children
            It's a small study, that hasn't  66,000 new infections a day,  er,  working  their  way  to  as  It's not clear how quickly the  volunteering  for  the  needle
            yet  been  published,  so  an-  are rising again and deaths are  young as 6-month-old.  FDA  would  act  on  Pfizer's  pricks, blood tests and other
            other important piece of evi-  averaging nearly 1,000 a day.                           request  to  allow  vaccination  tasks a study entails.
            dence  is  how  well  the  shots  Centers for Disease Control  “We are longing for a normal  starting at age 12. The agency  “We need kids to do these tri-
            revved up the kids’ immune  and  Prevention  director  Dr.  life.  This  is  especially  true  has taken about three weeks  als  so  that  kids  can  get  pro-
            systems. Researchers report-  Rochelle  Walensky  warned  for our children,” BioNTech  to review and authorize each  tected.  Adults  can’t  do  that
            ed high levels of virus-fight-  Americans  again  Wednesday  CEO  Ugur  Sahin  said  in  a  of  the  vaccines  currently  for them,” Chung said.
   24   25   26   27   28   29   30   31   32   33   34